Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Orgenesis (ORGS) just unveiled an announcement.
Curtis Slipman resigned from his director position at Orgenesis Inc. for personal reasons, not due to any disagreements with the company. Shortly after, Dr. Itzhak Vider was appointed to fill the vacancy and also joined the Audit Committee, meeting the independence standards of Nasdaq. Dr. Vider received stock options as part of the company’s compensation policy for non-employee directors, with a portion vesting annually over three years.
For detailed information about ORGS stock, go to TipRanks’ Stock Analysis page.
